Schwab Andrew J. sold Skye Bioscience ($SKYE) shares on the open market four times over the past year, totaling about $801,000. His most recent sale occurred on August 22, 2025. These sales rank him 5,416th among 11,678 individual insiders by value sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases of $SKYE in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 39,665,927 | 9999.99% | 0.19% |
| Feb. 6, 2026 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 39,665,927 | 9999.99% | 0.09% |
| Sept. 11, 2025 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Not found | A | Common Stock | 2941176 | $1.53 | 5,869,091.0000 | 20,161,072 | 100.45% | 14.59% |
| Aug. 21, 2025 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 58642 | $3.57 | 9,845,742.0000 | 36,486,519 | 0.59% | 0.16% |
| Aug. 22, 2025 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 6470 | $3.42 | 9,681,763.0000 | 36,486,519 | 0.07% | 0.02% |
| Aug. 22, 2025 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 163979 | $3.42 | 9,681,763.0000 | 36,486,519 | 1.67% | 0.45% |
| Aug. 21, 2025 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 2314 | $3.57 | 9,688,233.0000 | 36,486,519 | 0.02% | 0.01% |
| June 25, 2025 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| Feb. 24, 2025 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 36,486,519 | 9999.99% | 0.10% |
| Oct. 28, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 38,819,387 | 9999.99% | 0.18% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Common Stock | 1337592 | $0.00 | 1,337,592.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Series B Preferred Stock | 3395816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Series B Preferred Stock | 4244770 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Series A Prime Preferred Stock | 15002166 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | P | Common Stock | 909090 | $11.00 | 2,625,145.0000 | 0 | 52.98% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Common Stock | 302770 | $0.00 | 302,770.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Schwab Andrew J. | Director | C | Common Stock | 378463 | $0.00 | 1,716,055.0000 | 0 | 28.29% | 0.00% |
| Sept. 13, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 2000 | $6.06 | 9,913,168.0000 | 7,006,038 | 0.02% | 0.03% |
| Sept. 11, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 214556 | $6.60 | 9,924,926.0000 | 7,006,038 | 2.12% | 3.06% |
| Sept. 13, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 79 | $6.06 | 9,913,168.0000 | 7,006,038 | 0.00% | 0.00% |
| Sept. 11, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 36504 | $6.60 | 9,915,168.0000 | 7,006,038 | 0.37% | 0.52% |
| Sept. 13, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 11758 | $6.06 | 9,913,168.0000 | 7,006,038 | 0.12% | 0.17% |
| Sept. 11, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | S | Common Stock | 1440 | $6.60 | 9,913,247.0000 | 7,006,038 | 0.01% | 0.02% |
| March 13, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Not found | A | Common Stock | 450000 | $10.00 | 10,179,505.0000 | 7,006,038 | 4.63% | 6.42% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 7,006,038 | 9999.99% | 0.50% |
| Jan. 31, 2024 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 5206074 | $2.31 | 9,729,505.0000 | 7,006,038 | 115.09% | 74.31% |
| Nov. 6, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 14110 | $0.00 | 20,001.0000 | 0 | 239.52% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 1472692 | $0.00 | 1,472,692.0000 | 0 | 9999.99% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 684361447 | $0.01 | 1,130,857,157.0000 | 0 | 153.27% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 161944872 | $0.01 | 1,130,857,157.0000 | 0 | 16.71% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 6389921 | $0.01 | 1,130,857,157.0000 | 0 | 0.57% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 10558878 | $0.00 | 1,124,467,236.0000 | 0 | 0.95% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Warrant (Right to Buy) | 426348120 | $0.00 | 426,348,120.0000 | 0 | 9999.99% | 0.00% |
| Aug. 18, 2023 | Skye Bioscience, Inc. | $SKYE | Schwab Andrew J. | Director | A | Common Stock | 267602039 | $0.00 | 968,912,285.0000 | 0 | 38.16% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Schwab Andrew J. | Director | A | Stock Option (right to buy) | 27567 | $0.00 | 27,567.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Schwab Andrew J. | Director | A | Common Stock | 960383 | $0.00 | 960,383.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Schwab Andrew J. | Director | A | Common Stock | 4838092 | $0.00 | 4,838,092.0000 | 0 | 9999.99% | 0.00% |